36
Participants
Start Date
January 31, 2006
Primary Completion Date
January 31, 2008
Study Completion Date
January 31, 2008
Metformin
Metformin 500 mg. tabs 2 tabs BID for duration of study
Oral Contraceptive Pill
"Yasmin, drospirenone and ethinyl estradiol 28 tablets~1 tab daily for duration of study"
Lifestyle Management Program
Subjects and a parent/guardian will participate in a series of classes for training in diet, exercise \& behavior modification skills on a regular weekly basis over the 24 week study
Quality of Life Questionnaire
Quality of Life questionnaire designed for women with Polycystic Ovary Syndrome. Questions concern health and health related issues Performed twice during study, at baseline and conclusion
Oral Glucose Tolerance Test
"Insulin response to a glucose challenge in an oral glucose tolerance test (OGTT), as measured by area under the curve (AUC). In this study we will administer an OGTT and calculate the AUC as a measure of insulin resistance.~Performed twice during study, at baseline and conclusion"
Blood work
Initial and conclusion blood draws include; comprehensive metabolic profile, CBC and platelet,hormonal assessment and lipids.
Abdominal Ultra Sound
"transabdominal transducer, which contains integrated software for volume calculation will be used to assess ovarian volume.~Performed twice during study, at baseline and conclusion"
Dual-energy x-ray absorptiometry (DEXA scan)
Dual-energy x-ray absorptiometry (DEXA) will be used to assess percent body fat Performed twice during study, at baseline and conclusion
placebo
placebo capsules, two capsules BID
University of Rochester Medical Center, Rochester
University of Rochester
OTHER